The exome sequencing of a large set of patients with familial pancreatic cancer demonstrated that inherited pancreatic cancer is highly heterogeneous: in these patients, germline mutations of ATM, BRCA2, CDKN2A and PALB2 are observed, all elevating risk of developing pancreatic cancer [47]. This evidence concerns the gene PALB2 and familial pancreatic carcinoma.